Our study comprehensively explored the application of dabigatran in atrial fibrillation, cardioembolic stroke, and knee replacement, and other diseases to explore the relationship between CES1 rs2244613 and dabigatran PKs and bleeding risk. The gene discussed is CES1; the disease is cardioembolic stroke.